Back to search
Pulmonary Alveolar Proteinosis, Autoimmune
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Alveolar Proteinosis, Autoimmune trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pulmonary Alveolar Proteinosis, Autoimmune trials you may qualify forAutoimmune pulmonary alveolar proteinosis (aPAP) is a rare disorder in which a material called surfactant builds up in the lungs and makes it hard to breathe. I…
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be randomized to receive once daily treatment with inhaled molgramostim (MOL) or placebo…
This study aims to explore a new therapeutic approach: the feasibility, safety and preliminary efficacy of directly spraying GM-CSF into the airway through bron…